<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>PURPOSE: UbcH10 is the <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e>-related E2 ubiquitin-conjugating enzyme, and its overexpression has been demonstrated in a variety of <z:e sem="disease" ids="C0006826" disease_type="Neoplastic Process" abbrv="">malignancies</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>The aim of this study is to investigate the association of UbcH10 gene expression with the <z:e sem="disease" ids="C0596263" disease_type="Neoplastic Process" abbrv="">carcinogenesis</z:e> and <z:e sem="disease" ids="C0178874" disease_type="Neoplastic Process" abbrv="">tumor progression</z:e> of <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> </plain></SENT>
<SENT sid="2" pm="."><plain>METHODS: The expression levels of UbcH10 in human malignant colorectal <z:mp ids='MP_0002038'>carcinoma</z:mp> tissues and their adjacent <z:mpath ids='MPATH_458'>normal</z:mpath> tissues were examined using real-time quantitative RT-PCR and immunohistochemical analysis </plain></SENT>
<SENT sid="3" pm="."><plain>The correlations of UbcH10 expression to the clinicalpathologic characteristics of the <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> were analyzed </plain></SENT>
<SENT sid="4" pm="."><plain>Cell proliferation and Matrigel invasion assays were performed in HT-29 cells transfected with UbcH10 expression plasmid pcDNA3.1-UbcH10, UbcH10 <z:chebi fb="40" ids="33697">RNA</z:chebi> interference vector pUbcH10-RNAi as well as their control vectors </plain></SENT>
<SENT sid="5" pm="."><plain>RESULTS: Our study demonstrated that the expression of UbcH10 in colorectal <z:mp ids='MP_0002038'>carcinoma</z:mp> tissues was significantly higher than that in non-cancerous tissues (P &lt; 0.01), and the UbcH10 overexpression was related to the degree of <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> differentiation and lymph node <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastasis</z:e> of <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> patients (P &lt; 0.05) </plain></SENT>
<SENT sid="6" pm="."><plain>In vitro, the overexpression of UbcH10 promoted cell proliferation and <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> invasiveness, but the downregulation of UbcH10 expression significantly reduced the growth rate and the invasiveness activity of <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> cell line </plain></SENT>
<SENT sid="7" pm="."><plain>CONCLUSIONS: Our study suggests that the overexpression of UbcH10 gene plays a critical role in the <z:e sem="disease" ids="C0596263" disease_type="Neoplastic Process" abbrv="">carcinogenesis</z:e> and <z:e sem="disease" ids="C0178874" disease_type="Neoplastic Process" abbrv="">tumor progression</z:e> of <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> </plain></SENT>
<SENT sid="8" pm="."><plain>It may be a new marker in diagnosis and prognosis of <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e>, and the inhibition of UbcH10 may be a therapeutic potential for the treatment of <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> </plain></SENT>
</text></document>